Published on 6/1/2007 in the Prospect News PIPE Daily.
New Issue: Med BioGene closes private placement of units for C$3.07 million
By Laura Lutz
Des Moines, June 1 - Med BioGene Inc. settled a private placement of units for C$3,067,204.
The company sold 6,816,008 units of one share and one half-share warrant at C$0.45 per unit. Each whole warrant is exercisable at C$0.65 for three years.
Proceeds will be used to develop the company's diagnostic and prognostic product pipeline and for general corporate purposes.
Med BioGene is a Vancouver, B.C.-based biotechnology company focused on genetic biomarkers.
| Issuer: | Med BioGene Inc.
|
| Issue: | Units of one share and one half-share warrant
|
| Amount: | C$3,067,204
|
| Units: | 6,816,008
|
| Price: | C$0.45
|
| Warrants: | One half-share warrant per unit
|
| Warrant expiration: | Three years
|
| Warrant strike price: | C$0.65
|
| Settlement date: | June 1
|
| Stock symbol: | TSX Venture: MBI
|
| Stock price: | C$0.50 at close June 1
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
